I. Campbell

发表

National Breast Cancer Audit: overview of invasive breast cancer in New Zealand.

J. Kollias, C. Ooi, I. Campbell, 2012, The New Zealand medical journal.

Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

J. Cuzick, J. Forbes, V. Gebski, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Urban Rural Differences in Breast Cancer in New Zealand

M. Elwood, D. Sarfati, R. Lawrenson, 2016, International journal of environmental research and public health.

A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2017, BMC Health Services Research.

Initial axillary surgery: results from the BreastSurgANZ Quality Audit

G. Maddern, J. Kollias, A. Spillane, 2015, ANZ journal of surgery.

Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.

J. Forbes, R. Gelber, A. Goldhirsch, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.

G. Maddern, J. Kollias, A. Spillane, 2013, Breast.

Sentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial

M. Stockler, V. Gebski, R. Simes, 2015, Annals of surgical oncology.

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.

J. Forbes, P. Neven, C. Barrios, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Effective inhibition of aromatase inhibitor‐associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

P. Neven, G. von Minckwitz, A. Monnier, 2008, Cancer.

Treatment delay for Māori women with breast cancer in New Zealand

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2015, Ethnicity & health.

Adherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand?

A. Pillai, N. Scott, R. Lawrenson, 2015, Breast.

Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand.

D. Roder, J. Kollias, N. Scott, 2015, Asian Pacific journal of cancer prevention : APJCP.

Factors predictive of treatment by Australian breast surgeons of invasive female breast cancer by mastectomy rather than breast conserving surgery.

D. Roder, J. Kollias, H. Zorbas, 2013, Asian Pacific journal of cancer prevention : APJCP.

Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the Society of Breast Surgeons of Australia and New Zealand.

D. Roder, J. Kollias, C. Pyke, 2012, Asian Pacific journal of cancer prevention : APJCP.

Risk factors associated with mortality from breast cancer in Waikato, New Zealand: a case-control study.

J. Elwood, N. Scott, R. Lawrenson, 2015, Public health.

Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia.

D. Roder, J. Kollias, H. Zorbas, 2014, Australian health review : a publication of the Australian Hospital Association.

Adherence to recommended treatments for early invasive breast cancer: decisions of women attending surgeons in the breast cancer audit of Australia and New Zealand.

D. Roder, J. Kollias, C. Pyke, 2012, Asian Pacific journal of cancer prevention : APJCP.

Identification of the sentinel lymph node in the SNAC‐1 trial

M. Stockler, V. Gebski, J. Simes, 2015, ANZ journal of surgery.

Risk factors for poorer breast cancer outcomes in residents of remote areas of Australia.

D. Roder, J. Kollias, H. Zorbas, 2013, Asian Pacific journal of cancer prevention : APJCP.

Breast cancer survival in New Zealand women

D. Roder, J. Kollias, N. Scott, 2015, ANZ journal of surgery.

Title : Impact of mammographic screening on ethnic and socioeconomic 1 inequities in breast cancer stage at diagnosis and survival in New Zealand : 2 A cohort study

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2014 .

Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.

R. Gelber, A. Goldhirsch, K. Price, 2009, Breast.

Impact of Zoledronic Acid in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST, ZO-FAST, and E-ZO-FAST.

P. Neven, C. Barrios, A. Brufsky, 2009 .

Gebski, M. Stockler, J. Kollias, 2004 .

A randomized trial comparing axillary clearance versus no axillary clearance in older patients (≥ 60 years) with breast cancer: First results of International Breast Cancer Study Group Trial 10-93.

J. Forbes, D. Zahrieh, D. Crivellari, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved Breast Cytology Results with Near Patient FNA Diagnosis

Adam Bartlett, I. Campbell, F. Mayall, 2002, Acta Cytologica.

To infiltrate or not? Acute effects of local anaesthetic in breast surgery

I. Campbell, Emily Kerr, Shramana M. Banerjee, 2015, ANZ journal of surgery.

Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2015, PloS one.

Age effects on survival from early breast cancer in clinical settings in Australia

D. Roder, J. Kollias, H. Zorbas, 2012, ANZ journal of surgery.

Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2015, BMC Public Health.

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results.

J. Forbes, P. Neven, C. Barrios, 2013 .

Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis

R. Lawrenson, M. Kuper-Hommel, I. Campbell, 2017, Breast Cancer Research and Treatment.

Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.

I. Campbell, I. Campbell, M. Dray, 2001, The New Zealand medical journal.

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.

T. Whelan, I. Kunkler, J. Maduro, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Survival from breast cancer: an analysis of Australian data by surgeon case load, treatment centre location, and health insurance status.

D. Roder, J. Kollias, H. Zorbas, 2012, Australian health review : a publication of the Australian Hospital Association.

Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study

N. Scott, R. Lawrenson, M. Kuper-Hommel, 2014, BMC Cancer.

Sentinel node biopsy and large (≥3 cm) breast cancer

M. Stockler, V. Gebski, G. Farshid, 2014, ANZ journal of surgery.

Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia.

D. Roder, J. Kollias, C. Taylor, 2013, Breast.

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

R. Marshall, V. Harvey, R. Lawrenson, 2018, BMC Cancer.

Ethnic differences in breast cancer survival in New Zealand: contributions of differences in screening, treatment, tumor biology, demographics and comorbidities

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2015, Cancer Causes & Control.

Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer.

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2014, Cancer epidemiology.

Anxiety before, during, and after participation in a population-based screening mammography programme in Waikato Province, New Zealand.

M. Brunton, I. Campbell, Claire Jordan, 2005, The New Zealand medical journal.

Use of Non-Cancer Medications in New Zealand Women at the Diagnosis of Primary Invasive Breast Cancer: Prevalence, Associated Factors and Effects on Survival

S. Tin Tin, J. Elwood, D. Sarfati, 2020, International journal of environmental research and public health.

Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial

M. Stockler, P. Butow, C. Bonner, 2015, Clinical trials.

Patients' perceptions of health-related quality of life during and after adjuvant radiotherapy for T1N0M0 breast cancer.

M. Stockler, A. Rodger, D. Joseph, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema

M. Stockler, V. Gebski, J. Simes, 2017, Annals of surgical oncology.

Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)

M. Stockler, V. Gebski, R. Simes, 2008, Breast Cancer Research and Treatment.

Breast cancer inequities between Māori and non-Māori women in Aotearoa/New Zealand.

N. Scott, R. Lawrenson, Sanjeewa Seneviratne, 2016, European journal of cancer care.

Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women’s Wellness After Breast Cancer (YWWACP) lifestyle intervention

D. Anderson, J. Porter-Steele, S. Benge, 2022, Pilot and Feasibility Studies.

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection

M. Stockler, V. Gebski, G. Farshid, 2023, Breast.

Effective inhibition of aromatase inhibitor‐associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

P. Neven, G. von Minckwitz, A. Monnier, 2008, Cancer.

Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study

M. Brennan, A. Spillane, F. Boyle, 2023, Breast.

Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia.

D. Roder, J. Kollias, C. Pyke, 2013, Breast.

Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index

R. Marshall, V. Harvey, R. Lawrenson, 2018, BMC Cancer.

Final analysis of a randomized comparison of letrozole (Let) vs observation (Obs) as late reintroduction of adjuvant endocrine therapy (AET) for postmenopausal women with hormone receptor positive (HR+) breast cancer (BC) after completion of prior AET: ANZBCTG 0501 (LATER).

J. Forbes, V. Gebski, F. Boyle, 2015 .

Survival from breast cancer: an analysis of Australian data by surgeon case load, treatment centre location, and health insurance status.

D. Roder, J. Kollias, H. Zorbas, 2012, Australian health review : a publication of the Australian Hospital Association.